Traders purchased shares of Procter & Gamble Co (NYSE:PG) on weakness during trading hours on Wednesday. $185.13 million flowed into the stock on the tick-up and $99.99 million flowed out of the stock on the tick-down, for a money net flow of $85.14 million into the stock. Of all companies tracked, Procter & Gamble had the 9th highest net in-flow for the day. Procter & Gamble traded down ($1.10) for the day and closed at $80.24
A number of analysts have recently issued reports on PG shares. Jefferies Group reaffirmed a “buy” rating and issued a $99.00 price target on shares of Procter & Gamble in a research note on Monday, December 18th. Morgan Stanley lifted their price target on Procter & Gamble from $90.00 to $92.00 and gave the stock an “equal weight” rating in a research note on Thursday, January 25th. Stifel Nicolaus lifted their price target on Procter & Gamble from $87.00 to $88.00 and gave the stock a “hold” rating in a research note on Wednesday, January 24th. JPMorgan Chase & Co. lifted their price target on Procter & Gamble from $90.00 to $98.00 and gave the stock a “neutral” rating in a research note on Wednesday, January 24th. Finally, Deutsche Bank started coverage on Procter & Gamble in a research note on Tuesday, December 19th. They issued a “buy” rating and a $91.88 price target on the stock. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the stock. Procter & Gamble currently has a consensus rating of “Buy” and a consensus price target of $88.11.
The firm has a market capitalization of $202,290.00, a PE ratio of 21.69, a P/E/G ratio of 2.58 and a beta of 0.51. The company has a quick ratio of 0.79, a current ratio of 0.94 and a debt-to-equity ratio of 0.41.
Procter & Gamble (NYSE:PG) last announced its quarterly earnings data on Tuesday, January 23rd. The company reported $1.19 EPS for the quarter, topping the Zacks’ consensus estimate of $1.14 by $0.05. Procter & Gamble had a return on equity of 20.66% and a net margin of 15.34%. The firm had revenue of $17.40 billion for the quarter, compared to the consensus estimate of $17.39 billion. During the same quarter last year, the business posted $1.08 earnings per share. The firm’s revenue was up 3.2% compared to the same quarter last year. equities research analysts expect that Procter & Gamble Co will post 4.21 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which was paid on Thursday, February 15th. Shareholders of record on Friday, January 19th were given a $0.6896 dividend. The ex-dividend date was Thursday, January 18th. This represents a $2.76 dividend on an annualized basis and a yield of 3.44%. Procter & Gamble’s dividend payout ratio is currently 74.59%.
In other Procter & Gamble news, insider Juan Fernando Posada sold 9,005 shares of Procter & Gamble stock in a transaction on Thursday, February 15th. The stock was sold at an average price of $82.09, for a total value of $739,220.45. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, insider R. Alexandra Keith sold 1,298 shares of Procter & Gamble stock in a transaction on Wednesday, November 29th. The shares were sold at an average price of $89.11, for a total value of $115,664.78. Following the completion of the sale, the insider now owns 20,135 shares in the company, valued at approximately $1,794,229.85. The disclosure for this sale can be found here. Insiders sold 71,928 shares of company stock worth $6,312,311 in the last 90 days. Company insiders own 0.35% of the company’s stock.
A number of large investors have recently bought and sold shares of PG. Signature Estate & Investment Advisors LLC acquired a new stake in shares of Procter & Gamble in the fourth quarter valued at $103,000. Asset Planning Services Ltd. grew its stake in shares of Procter & Gamble by 0.4% in the second quarter. Asset Planning Services Ltd. now owns 1,191 shares of the company’s stock valued at $104,000 after buying an additional 5 shares in the last quarter. Earnest Partners LLC acquired a new stake in shares of Procter & Gamble in the fourth quarter valued at $110,000. Cerebellum GP LLC acquired a new stake in shares of Procter & Gamble in the fourth quarter valued at $122,000. Finally, Harding Loevner LP acquired a new stake in shares of Procter & Gamble in the second quarter valued at $119,000. Institutional investors own 59.78% of the company’s stock.
WARNING: This piece was originally posted by The Lincolnian Online and is owned by of The Lincolnian Online. If you are accessing this piece on another site, it was stolen and republished in violation of international copyright & trademark laws. The legal version of this piece can be viewed at https://www.thelincolnianonline.com/2018/02/21/investors-buy-shares-of-procter-gamble-pg-on-weakness.html.
Procter & Gamble Company Profile
The Procter & Gamble Company is focused on providing branded consumer packaged goods to the consumers across the world. The Company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care, and Baby, Feminine & Family Care. The Company sells its products in approximately 180 countries and territories primarily through mass merchandisers, grocery stores, membership club stores, drug stores, department stores, distributors, baby stores, specialty beauty stores, e-commerce, high-frequency stores and pharmacies.
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.